Showing results (111-120 of 954) with videos related to
Sort By:
Pageof 96
Cancer Research|February 1, 1995
Anti-CD54 (ICAM-1) has antitumor activity in SCID mice with human myeloma cellsY W Huang, J A Richardson, E S VitettaTrends in Pharmacological Sciences|May 1, 1993
Immunotoxins: magic bullets or misguided missiles?E S Vitetta, P E Thorpe, J W UhrCellular Immunology|February 1, 1987
Antigen-specific memory and virgin B cells differ in their requirements for conjugation to T cellsV M Sanders, J W Uhr, E S VitettaCancer Research|March 1, 1991
Covalent binding of human alpha 2-macroglobulin to deglycosylated ricin A chain and its immunotoxinsM A Ghetie, J W Uhr, E S VitettaCellular Immunology|October 15, 1991
Changes in expression of J11d on murine B cells during activation and generation of memoryX M Yin, W T Lee, E S VitettaThe Journal of Experimental Medicine|July 1, 1984
Cytotoxicity of a cell-reactive immunotoxin containing ricin A chain is potentiated by an anti-immunotoxin containing ricin B chainE S Vitetta, R J Fulton, J W UhrCancer Research|May 1, 1988
In vivo therapy of the BCL1 tumor: effect of immunotoxin valency and deglycosylation of the ricin A chainR J Fulton, J W Uhr, E S VitettaEuropean Journal of Immunology|June 1, 1979
Identification of autoanti-Thi-1 antibody in the sera of BALB/c mice immune to P1798 lymphomaF S Baechtel, M D Prager, E S VitettaJournal of Immunology (Baltimore, Md. : 1950)|March 1, 1977
Relationship between trinitrophenyl and H-2 antigens on trinitrophenyl-modified spleen cells. I. H-2 antigens on cells treated with trinitrobenzene sulfonic acid are derivatizedJ Forman, E S Vitetta, D A Hart, et al.Critical Reviews in Eukaryotic Gene Expression|November 10, 1998
The development of monoclonal antibodies for the therapy of cancerR A Farah, B Clinchy, L Herrera, et al.Pageof 96